Literature DB >> 23887748

Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis.

Nobuaki Shiraki1, Ayumu Nakashima, Shigehiro Doi, Juan Jesús Carrero, Naoko Sugiya, Toshinori Ueno, Peter Stenvinkel, Nobuoki Kohno, Takao Masaki.   

Abstract

BACKGROUND: Low serum testosterone levels have been recently linked to endothelial dysfunction, arterial stiffness, and worse outcomes in male hemodialysis patients. We tested the hypothesis that low serum testosterone levels are also associated with atherosclerosis risk factors in postmenopausal women undergoing hemodialysis.
METHODS: We measured serum testosterone in 115 confirmed postmenopausal ethnically Japanese women undergoing hemodialysis with mean age of 68.1 ± 10.6 years and median dialysis vintage of 73 months. The severity of atherosclerosis was evaluated by carotid intima-media thickness (cIMT) and cardio-ankle vascular index (CAVI). In addition, we also included a control cohort of 32 age-matched postmenopausal women without chronic kidney disease.
RESULTS: Serum testosterone was significantly lower in women undergoing hemodialysis than in age-matched controls. Women undergoing hemodialysis who had undetectable testosterone concentration presented higher cIMT and higher CAVI than women undergoing hemodialysis with testosterone concentration above detection limits (P < 0.05 for all). Multiple logistic regression analyses confirmed the independence of these associations.
CONCLUSION: Serum testosterone levels in postmenopausal women undergoing hemodialysis are abnormally low and associated with features of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23887748     DOI: 10.1007/s10157-013-0840-6

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  46 in total

1.  A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI).

Authors:  Kohji Shirai; Junji Utino; Kuniaki Otsuka; Masanobu Takata
Journal:  J Atheroscler Thromb       Date:  2006-04       Impact factor: 4.928

2.  Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD.

Authors:  Juan Jesús Carrero; John Kyriazis; Alper Sonmez; Ioannis Tzanakis; Abdul Rashid Qureshi; Peter Stenvinkel; Mutlu Saglam; Kostas Stylianou; Halil Yaman; Abdullah Taslipinar; Abdulgaffar Vural; Mahmut Gok; Mujdat Yenicesu; Eugene Daphnis; Mahmut Ilker Yilmaz
Journal:  Clin J Am Soc Nephrol       Date:  2011-12-22       Impact factor: 8.237

3.  Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients.

Authors:  John Kyriazis; Ioannis Tzanakis; Kostas Stylianou; Irene Katsipi; Demitrios Moisiadis; Antonia Papadaki; Vasiliki Mavroeidi; Stella Kagia; Nikolaos Karkavitsas; Eugene Daphnis
Journal:  Nephrol Dial Transplant       Date:  2011-03-21       Impact factor: 5.992

4.  Reduced number of circulating endothelial progenitor cells in hypogonadal men.

Authors:  C Foresta; N Caretta; A Lana; L De Toni; A Biagioli; A Ferlin; A Garolla
Journal:  J Clin Endocrinol Metab       Date:  2006-08-22       Impact factor: 5.958

5.  Sexual dysfunction in women with ESRD requiring hemodialysis.

Authors:  Giovanni F M Strippoli; Mariacristina Vecchio; Suetonia Palmer; Giorgia De Berardis; Jonathan Craig; Giuseppe Lucisano; David Johnson; Fabio Pellegrini; Antonio Nicolucci; Michela Sciancalepore; Valeria Saglimbene; Letizia Gargano; Carmen Bonifati; Marinella Ruospo; Sankar D Navaneethan; Vincenzo Montinaro; Paul Stroumza; Marianna Zsom; Mariatta Torok; Eduardo Celia; Ruben Gelfman; Anna Bednarek-Skublewska; Jan Dulawa; Giusi Graziano; Giorgio Gentile; Juan Nin Ferrari; Antonio Santoro; Annalisa Zucchelli; Giorgio Triolo; Stefano Maffei; Jörgen Hegbrant; Charlotta Wollheim; Salvatore De Cosmo; Valeria M Manfreda
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-05       Impact factor: 8.237

6.  Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men.

Authors:  Marianna Yaron; Yona Greenman; Joseph B Rosenfeld; Elena Izkhakov; Rona Limor; Etty Osher; Galina Shenkerman; Karen Tordjman; Naftali Stern
Journal:  Eur J Endocrinol       Date:  2009-01-27       Impact factor: 6.664

7.  Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor.

Authors:  Joanne E Nettleship; T Hugh Jones; Kevin S Channer; Richard D Jones
Journal:  Circulation       Date:  2007-11-05       Impact factor: 29.690

Review 8.  Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM).

Authors:  Juan Jesús Carrero; Peter Stenvinkel; Lilian Cuppari; T Alp Ikizler; Kamyar Kalantar-Zadeh; George Kaysen; William E Mitch; S Russ Price; Christoph Wanner; Angela Y M Wang; Pieter ter Wee; Harold A Franch
Journal:  J Ren Nutr       Date:  2013-03       Impact factor: 3.655

9.  Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence.

Authors:  I Wendelhag; O Wiklund; J Wikstrand
Journal:  Arterioscler Thromb       Date:  1993-10

10.  Endogenous testosterone, muscle strength, and fat-free mass in men with chronic kidney disease.

Authors:  Secundino Cigarrán; Montserrat Pousa; María Jesús Castro; Berta González; Aurelia Martínez; Guillermina Barril; Abelardo Aguilera; Francisco Coronel; Peter Stenvinkel; Juan Jesús Carrero
Journal:  J Ren Nutr       Date:  2012-10-06       Impact factor: 3.655

View more
  6 in total

1.  Association of free testosterone and sex hormone binding globulin with metabolic syndrome and subclinical atherosclerosis but not blood pressure in hypertensive perimenopausal women.

Authors:  Agnieszka Olszanecka; Kalina Kawecka-Jaszcz; Danuta Czarnecka
Journal:  Arch Med Sci       Date:  2016-05-18       Impact factor: 3.318

2.  Relationship Between Serum Total Testosterone Concentration and Augmentation Index at Radial Artery in Japanese Postmenopausal Patients.

Authors:  Takashi Hitsumoto
Journal:  J Clin Med Res       Date:  2017-09-01

3.  Analysis of biomarkers and metabolic pathways in patients with unstable angina based on ultra‑high‑performance liquid chromatography‑quadrupole time‑of‑flight mass spectrometry.

Authors:  Yuechen Liu; Yue Li; Tianpu Zhang; Huan Zhao; Simiao Fan; Xuemeng Cai; Yijia Liu; Zhu Li; Shan Gao; Yubo Li; Chunquan Yu
Journal:  Mol Med Rep       Date:  2020-09-02       Impact factor: 2.952

4.  Serum Testosterone Levels Are Not Modified by Vitamin D Supplementation in Dialysis Patients and Healthy Subjects.

Authors:  Christof Ulrich; Bogusz Trojanowicz; Roman Fiedler; Frank Bernhard Kraus; Gabriele I Stangl; Matthias Girndt; Eric Seibert
Journal:  Nephron       Date:  2021-06-09       Impact factor: 2.847

5.  Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients.

Authors:  Alper Kirkpantur; Mustafa Balci; Aysel Turkvatan; Baris Afsar
Journal:  Clin Kidney J       Date:  2015-08-27

6.  Testosterone and dihydrotestosterone reduce platelet activation and reactivity in older men and women.

Authors:  Kamil Karolczak; Lucyna Konieczna; Tomasz Kostka; Piotr J Witas; Bartlomiej Soltysik; Tomasz Baczek; Cezary Watala
Journal:  Aging (Albany NY)       Date:  2018-05-02       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.